论文部分内容阅读
目的 :评价超选择性肝动脉内化疗加碘油乳剂和明胶海绵栓塞治疗原发性肝癌的疗效。方法 :对 1 0 5例原发性肝癌 ,共行 2 30次介入治疗 ,采用Seldinger法经股动脉插管 ,送入 5F或 6F肝导管超选择至肝癌供血动脉 ,灌注化疗药物加碘油乳剂和明胶海绵栓塞供血动脉。结果 :1 0 5例原发性肝癌 1～ 2年生存率为 38% ,单结节巨块型和富血肿瘤疗效 ( 1～ 2年生存率 4 8% )好于多结节弥漫型及乏血肿瘤 ( 1～ 2年生存率 1 8% )。结论 :超选择性肝动脉内化疗加栓塞是治疗不能手术的中晚期肝癌的最有效方法之一。
Objective: To evaluate the efficacy of superselective intrahepatic arterial chemotherapy with lipiodol emulsion and gelatin sponge embolization in the treatment of primary liver cancer. Methods: Totally 105 cases of primary hepatocellular carcinoma (HCC) were treated with 2 30 interventional treatments. Seldinger method was used for femoral artery cannulation. 5F or 6F hepatic duct was surgically selected to the hepatic artery feeding artery. The chemotherapeutic drugs plus lipiodol emulsion And gelatin sponge embolization of the feeding artery. Results: The 1-year and 2-year survival rates of 105 cases of primary hepatocellular carcinoma were 38%. The therapeutic effect of single nodular bulky and blood-rich tumors (48-year survival rate of 48%) was better than that of multiple nodules Spent cancer (1 to 2 years survival rate of 18%). Conclusion: Superselective intrahepatic arterial chemoembolization is one of the most effective methods for the treatment of inoperable advanced hepatocellular carcinoma.